Skip to main content

Advertisement

Table 1 The clinical and demographical characteristics of pulmonary carcinoid cases

From: Clinical biomarkers of pulmonary carcinoid tumors in never smokers via profiling miRNA and target mRNA

  Cases for DASL-miRNA (N=47) Cases for DASL-mRNA (N=51) Cases for RNA-seq & Exon-seq (N=9)
Age at diagnosis    
N 47 51 9
Mean (SD) 62.2 (17.0) 63.0 (16.3) 57.4 (18.5)
Gender    
Female 31 (65.9%) 35 (68.6%) 6 (66.7%)
Male 16 (34.1) 16 (31.4%) 3 (33.3%)
Cell type    
Typical 44 (93.6%) 48(94.1%) 8 (88.9%)
Atypical 3 (6.4%) 3(5.9%) 1 (11.1%)
Tumor stage    
Stage I & II 36 (76.6%) 40 (78.4%) 9 (100%)
Stage III & IV 11 (23.4%) 11 (21.6%) 0 (0%)
Sample set    
FFPE 23 (48.9%) 26 (50.9%) --
FF 24 (51.0%) 25 (49.0%) 9 (100%)
Median follow-up period ( year ) 6.4 6.4 7.2
Events    
Yes 5 (10.6%) 5 (9.8%) 0 (0.00%)
No 42 (89.4%) 46 (90.2%) 9 (100%)